Lion's Mane
Lion's Mane (Hericium erinaceus) is an edible white mushroom with a long history of culinary and traditional use, particularly across East Asia. It is sold in the UK as a food supplement. There are no authorised UK health claims for Lion's Mane — its EFSA evaluation for cognitive and nervous-system claims remains on hold.
Camden Medicals editorial · Last reviewed 11 June 2026 · Next review September 2026
- Cross-checked against
- NHS
- NICE
- BNF
- EFSA
- FSA
Camden's editorial team independently graded each health claim below on the strength of the published evidence — see the grade beside every condition.
- Class
- Mushroom
- Typical daily dose
- Published human trials have used roughly 1.8–3.2 g/day of fruiting-body dry powder (Mori 2009: 3 g/day; Saitsu 2019: 3.2 g/day). Commercial UK supplements typically deliver the equivalent of 500–1,500 mg of mushroom per serving; daily totals vary widely and extract ratios are not standardised.
- Top use evidence
- Limited
On this page
What it is
Lion's Mane is a fungus in the order Russulales, native to North America, Europe, and East Asia. The white, shaggy fruiting body grows on broadleaf trees. Known as Yamabushitake (山伏茸) in Japan and Houtou (猴头菇) in China, it has been eaten as a food and used in traditional East Asian medicine for centuries.
Two parts of the fungus appear in commercial supplements: the fruiting body (the visible mushroom) and the mycelium (the underground filament network). The two have different chemical profiles. Many cheaper Lion's Mane supplements use mycelium grown on a grain substrate, which is then sold whole — the resulting powder is largely grain, not mushroom.
The compounds most discussed in the Lion's Mane research literature distribute differently between the two parts: specific beta-glucans and hericenones are concentrated in the fruiting body, while erinacines are produced primarily by the mycelium. Both compound families have been studied in cell-culture and animal models for nerve-growth-factor signalling.
At a glance
- Edible mushroom (Hericium erinaceus) sold as a food supplement in the UK.
- No UK-authorised health claims; EFSA evaluation on hold for botanicals.
- Quality of supplements varies enormously: fruit-body extract is what the literature studies; mycelium-on-grain is a much cheaper substrate that contains mostly grain.
- Not a treatment for dementia or cognitive impairment.
What people use it for
People including a culinary mushroom in their diet
Lion's Mane is an edible mushroom; it can be consumed as food.
Popular, not provenInsufficientPeople exploring traditional botanicals
Long history of traditional use in East Asia. The traditional-use frame is permissible; specific health claims are not.
Some evidenceLimitedPeople with cognitive impairment, dementia, or mental health conditions
Lion's Mane is not a treatment for these conditions. UK NHS pathways apply. Talk to your GP. [2,1]
Popular, not provenInsufficient
How it works
Animal and laboratory studies have explored Lion's Mane compounds in relation to nerve growth factor (NGF) signalling. The clinical significance of these findings in humans is not established.
Common myths
Myth"Lion's Mane regenerates neurons or cures dementia"
RealityAnimal and laboratory studies show effects on nerve growth factor signalling. No evidence supports Lion''s Mane as a treatment for dementia or cognitive impairment in humans. Marketing that uses these framings goes beyond what the evidence supports and beyond what is permitted under UK supplement-marketing rules. [1]
Myth"Mycelium-on-grain Lion's Mane is the same as fruit-body Lion's Mane"
RealityThey have substantially different chemical profiles. Mycelium-on-grain powders are largely grain by mass — beta-glucan content is dominated by the grain substrate, not the mushroom. Hericenones concentrate in the fruiting body; erinacines are produced primarily by the mycelium. Either way, what the cell-culture and animal literature studied is very different from what a grain-substrate powder typically delivers.
Myth"Higher polysaccharide percentage means a better extract"
RealityTotal polysaccharide percentage is a poor quality marker for mushroom supplements. Grain starch counts toward total polysaccharide. The relevant measure is beta-glucan percentage specifically.
Myth"A "10:1" or "12:1" extract is ten or twelve times stronger"
RealityExtract ratios describe how many kilograms of starting raw mushroom were processed to yield one kilogram of extract. They do not describe the concentration of any specific bioactive, and the starting material itself is not standardised. A 12:1 extract is not "12× stronger" than a 1:1 powder. Look for the beta-glucan percentage of the finished extract and the substrate (fruit body vs mycelium-on-grain) instead.
Common online questions
Synthesised from the questions UK shoppers most often ask online about Lion's Mane. Each answer is editorial and links to its evidence in the Sources list below.
Does Lion's Mane actually improve memory?
The evidence is early and small. Three frequently-cited human trials are Mori 2009 (N=30 with mild cognitive impairment, 16 weeks at 3 g/day fruit-body powder), Saitsu 2019 (N=31 with subjective cognitive complaints), and Vigna 2019 (N=77 adults with overweight or obesity, mood outcomes). All three are small, single-site, and have not been independently replicated at scale. EFSA''s evaluation of cognitive-function claims for Lion''s Mane has been on hold since 2010 and remains so. There is no GB-authorised health claim that Lion''s Mane improves memory. UK NHS pathways for cognitive concerns do not list Lion''s Mane. If memory loss is affecting daily life, see a GP. [7,8,9,1]
Fruiting body vs mycelium — which should I buy?
The fruiting body (the visible mushroom) is what most published human trials have used. Mycelium grown on a grain substrate is cheaper to produce; the resulting powder is largely grain starch by mass and the bioactives that the literature studied are present in lower amounts. If you want a supplement that matches what trials used, look for "fruiting body" explicitly on the label, with a stated beta-glucan percentage as the quality marker (not total polysaccharide, which counts grain starch).
What does "12:1 extract" mean — is it twelve times stronger?
No. Extract ratios describe how many kilograms of starting raw mushroom were processed to yield one kilogram of extract. They do not describe the concentration of any specific bioactive, and the starting material itself is not standardised. A "12:1 extract" is not "12× stronger" than a 1:1 powder. Look for the beta-glucan percentage of the finished extract and the substrate (fruit body vs mycelium-on-grain) instead.
Is Lion's Mane safe to take long-term?
Long-term safety in healthy adults is not well established. Published trials have used Lion''s Mane for up to 16 weeks at roughly 1.8–3.2 g/day of fruit-body powder; safety data beyond that comes from traditional culinary use of the mushroom as a food, which is a different exposure pattern from a concentrated extract. Memorial Sloan Kettering and NCBI LiverTox both note no significant long-term safety signals in the literature so far, but the absence of long trials is itself a limitation.
How long until I notice an effect?
The published trials that reported cognitive changes did so at 12–16 weeks of daily supplementation. None of those trials measured shorter time-points reliably. There is no UK authorised health claim that allows promising any specific timeline of effect; if you are not noticing a change, that is consistent with the modest and inconsistent published evidence. [7]
Can I take Lion's Mane with antidepressants or anti-anxiety medication?
There are no documented clinically-significant interactions between Lion''s Mane and SSRIs, SNRIs, or benzodiazepines in the published literature. That said, the safety database is small and stopping or starting a botanical alongside a prescribed mental-health medication is a conversation to have with your prescribing clinician — not a decision to make unilaterally. UK NHS pathways for anxiety and depression apply.
🔬 Camden’s evidence review
The research Camden reviewed, graded on its strength. This is our own appraisal — it sits beneath the official guidance above, never above it.
Cognitive function in healthy adults
LimitedEvidencelimitedUK and EU guidance does not recognise a cognitive benefit for Lion's Mane: the NHS dementia-risk guidance and NICE NG97 do not list it, and the GB health-claims register carries no authorised cognitive claim (see the Guidance section above). Beneath that authoritative position, Camden's own reading of the primary literature is consistent: a small number of human pilot trials (Mori 2009 PMID 18844328, N=30 with mild cognitive impairment, 16 weeks at 3 g/day fruit-body powder; Saitsu 2019 PMID 31413233) reported modest changes in cognitive scores during supplementation, with the effect falling back at washout in Mori 2009. Trial sizes are small, no large independent replication exists, and EFSA's botanical-claims evaluation for Lion's Mane remains on hold. [7,8,1]
Mild cognitive impairment / dementia
InsufficientEvidenceinsufficientThis is the clearest authority signal. The NHS does not list Lion''s Mane among ways to reduce dementia risk, NICE NG97 does not include it in dementia management, and the Alzheimer''s Society urges scepticism toward any supplement sold to prevent, slow or reverse dementia (see the Guidance section above). Camden''s reading of the primary literature agrees with that guidance: no human evidence supports Lion''s Mane as a treatment for dementia or cognitive impairment. [1]
Mood / anxiety
InsufficientEvidenceinsufficientNo UK or EU guidance recognises a mood or anxiety benefit for Lion''s Mane, and there is no authorised GB health claim (see the Guidance section above). Camden''s reading of the primary literature finds the evidence insufficient: the most-cited mood study (Vigna 2019, PMID 31118969, in adults with overweight or obesity, N=77) is too narrow to support a population-level claim, and EFSA''s botanical-claims evaluation is on hold. [9]
Safety
Lion's Mane is generally well tolerated in published trials, but long-term safety data in healthy adults is limited and EFSA has not authorised any UK health claim for it. Eating Lion's Mane as a culinary mushroom is a different question from a concentrated extract — pregnancy and complex medication routines deserve a pharmacist conversation.
Talk to your pharmacist or GP first if you:
- You have a known mushroom allergy.
- You take an anticoagulant (warfarin, apixaban, rivaroxaban, etc.) — animal data has hinted at platelet effects, so check before starting.
- You are pregnant, breastfeeding, or thinking of becoming pregnant — there is not enough safety data on Lion's Mane supplementation in pregnancy.
- You are immunosuppressed or have an active fungal infection.
- You are buying for cognitive symptoms in yourself or a family member — UK NHS pathways apply (see your GP); Lion's Mane is not a treatment for dementia.
Common side effects: Occasional mild digestive complaints (under ~10% of users in published trials). Rare hypersensitivity reactions including skin rash, and isolated case reports of respiratory symptoms.
Pregnancy and breastfeeding
There is insufficient safety data on Lion's Mane supplementation in pregnancy. Talk to your pharmacist or GP before supplementing during pregnancy. Eating Lion's Mane as a food (in cuisine) is a different situation from supplemental concentrated extracts.
Insufficient safety data — talk to your pharmacist or GP.
Talk to your GP, midwife, or pharmacist before starting any supplement during pregnancy or breastfeeding.
More clinical detail (for clinicians and informed readers)
Contraindications
- Known mushroom allergy.
Drug interactions
- No well-established clinically significant interactions in standard food-supplement use. Some animal data on platelet aggregation suggests caution if taking anticoagulants — discuss with your pharmacist or GP.
This is not an exhaustive list. Always tell your prescriber and pharmacist about every supplement you take.
Common side effects
- Generally well tolerated. Occasional mild digestive complaints reported.
Rare side effects
- Hypersensitivity reactions including skin rash and, in isolated case reports, respiratory symptoms (Nakatsugawa 2003).
How to take it
- Typical supplemental range
- Published human trials have used roughly 1.8–3.2 g/day of fruiting-body dry powder (Mori 2009: 3 g/day; Saitsu 2019: 3.2 g/day). Commercial UK supplements typically deliver the equivalent of 500–1,500 mg of mushroom per serving; daily totals vary widely and extract ratios are not standardised.
- Timing
- No specific timing requirement.
How to spot quality
Look for
- Substrate clearly stated: fruiting body extract is the form most discussed in the research literature.
- Beta-glucan percentage specifically (not just "polysaccharides").
- Extract ratio stated (e.g. 12:1) with the resulting mushroom-equivalent dose calculated.
- GMP-certified manufacture; ideally third-party testing for heavy metals (mushrooms can concentrate environmental metals).
- Country of cultivation disclosed.
Red flags
- Substrate not declared (fruit body vs mycelium vs mycelium-on-grain).
- "30% polysaccharides" presented as a quality marker — total polysaccharide is the wrong metric for mushroom supplements.
- Cognitive / memory / focus claims printed on the label (these claims are not authorised in the UK).
- Labels that conflate Lion's Mane with general "nootropic" marketing.
Commonly combined with
Other ingredients that share a biological pathway, cofactor relationship, or evidence-backed protocol with this one. Mechanisms below cite primary physiology — not folk pairing. Doses are literature ranges, not recommendations. Talk to your pharmacist or GP before changing your stack, especially if you take prescription medication.
Bacopa Monnieri (Brahmi)
Limited evidenceTwo cognitive nootropics with different mechanisms — frequently combined in cognitive stacks for complementary action.
Lion's Mane (Hericium erinaceus) hericenones (in the fruiting body) and erinacines (in the mycelium) are the two compound families with cell-culture evidence for stimulating nerve growth factor (NGF) synthesis. Bacopa monnieri bacosides act on a different axis — modulating brain-derived neurotrophic factor (BDNF), antioxidant defences, and cholinergic neurotransmission. The two are commonly stacked because their mechanisms are complementary rather than overlapping. Most published Lion's Mane and Bacopa trials test each compound alone; direct combination RCTs are rare. Bacopa requires sustained 8–12 week dosing for cognitive effects (Stough 2008); Lion's Mane evidence is mostly mechanistic with one well-cited Japanese MCI trial (Mori 2009).
Evidence: Mori 2009 (Phytother Res) RCT on Lion's Mane in mild cognitive impairment. Stough 2008 (Phytother Res) on Bacopa cognitive function in healthy adults. Combination evidence is mostly anecdotal and from commercial nootropic stacks, not direct trials. [7,10]
Doses studied: 500–1000 mg Lion's Mane (8:1 hot-water extract) with 300–450 mg Bacopa (50–55% bacoside extract) daily; minimum 8-week trial period for cognitive endpoints
Reishi
Limited evidenceLion's Mane and Reishi are the two most-bundled medicinal mushrooms in cognitive/immune complexes; the evidence base is largely mechanism + traditional use.
Lion's Mane (Hericium erinaceus) contains hericenones and erinacines that have been shown in vitro and in animal models to stimulate nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) expression — the mechanistic basis for its cognitive and mood claims. Reishi (Ganoderma lucidum) contains beta-D-glucan polysaccharides that interact with toll-like receptors on macrophages, dendritic cells, NK cells and lymphocytes, with measurable in vitro and animal-model immunomodulatory effects. The two mushrooms target different physiology — neurotrophic vs immune — and the combination rationale is system-coverage rather than direct synergy. Clinical evidence in humans for either mushroom alone is limited; combination evidence is essentially absent.
Evidence: Chong 2019 (Int J Mol Sci 21:163) reviewed Lion's Mane mechanism for depressive disorder, summarising NGF/BDNF pathway evidence. Samberkar 2015 (Int J Med Mushrooms 17:1047) demonstrated Lion's Mane neurite outgrowth in vitro. Xu 2011 (Am J Chin Med 39:15) reviewed Ganoderma lucidum polysaccharide immunomodulation evidence. No published RCTs evaluate the Lion's Mane + Reishi combination in humans; the combination rationale is mechanistic and traditional. [11,12,13]
Doses studied: Common product range: 500-1500 mg Lion's Mane (fruiting-body or dual-extract) + 500-1000 mg Reishi (dual-extract preferred for triterpenes + polysaccharides), divided across the day.
Cordyceps
Limited evidenceLion's Mane (cognitive) and Cordyceps (energy/oxygen utilisation) are stacked for combined mental + physical performance support; evidence is mostly individual-mushroom.
Lion's Mane (Hericium erinaceus) acts on neurotrophic pathways via hericenones and erinacines stimulating NGF and BDNF. Cordyceps (most often the cultivated Cordyceps militaris in modern supplements) contains cordycepin, adenosine analogues and beta-glucans, with evidence for effects on mitochondrial ATP turnover, exercise tolerance and immune modulation in animal and small human studies. The combination targets different systems (neurotrophic vs energetic) without a published direct interaction; co-administration is rationalised by complementary system coverage rather than pharmacodynamic synergy.
Evidence: Lion's Mane evidence as above (Chong 2019; Samberkar 2015). Cordyceps human trials are limited and heterogeneous, with positive small studies in exercise tolerance and fatigue but no large definitive RCTs. No combination RCTs exist. [11,12]
Doses studied: Common product range: 500-1500 mg Lion's Mane + 500-1500 mg Cordyceps daily, in divided doses.
Verifera™ editorial perspective
Why it matters. Lion's Mane is marketed widely for focus and memory, yet UK and EU regulators have not recognised any such benefit. Knowing where the authoritative guidance actually stands makes it easier to read a label critically before spending.
Where Camden lands. Camden retails Lion's Mane as a culinary-tradition food supplement only. We make no cognitive, memory or mood claim for it, and our listings carry no authorised health claim because none exists on the GB register.
If you want to explore further. For memory or cognitive changes, the appropriate first step in the UK is an NHS assessment — speak to your GP. For a general culinary mushroom supplement, the quality markers below apply to any brand.
How this entry was researched
Authoritative sources consulted:
- NHS — Can dementia be prevented? (reviewed 2023-07-31)
- NICE NG97 — Dementia (last updated 2025-10-24)
- Alzheimer's Society — Can I buy supplements to prevent or treat dementia?
- GB Nutrition and Health Claims register (gov.uk, updated 2026-05-19)
- EFSA — Article 13 general-function health claims (botanicals on hold)
- Memorial Sloan Kettering — About Herbs: Lion's Mane
- NCBI LiverTox — Lion's Mane (NBK599740)
PubMed search terms:
Hericium erinaceus cognition randomisedLion's Mane mild cognitive impairment trialHericium erinaceus mood anxiety
Literature search date: 2026-06-11
Sources listed are those consulted by the Verifera™ editorial team. Readers should verify against current authoritative sources.